FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to the field of medicine, namely to a drug for the prevention or treatment of cardiovascular diseases containing a first layer containing fimasartan potassium trihydrate, and a second layer containing rosuvastatin calcium, and amlodipine bezilate, where the second layer contains low-substituted hydroxypropyl cellulose.
EFFECT: present invention provides for the creation of a combined drug for the effective treatment of cardiovascular diseases containing fimasartan, amlodipine and rosuvastatin as effective components, which demonstrates an excellent dissolution profile and stability and improves patient compliance with the therapy regimen.
7 cl, 3 dwg, 2 tbl, 4 ex
Title |
Year |
Author |
Number |
PHARMACEUTICAL COMBINED DRUG |
2014 |
- Myung, Jayhyuk
- Nam, Kyung Wan
- Lee, Cheol Woo
- Kim, Ju Won
|
RU2639818C2 |
TABLET AND METHOD OF ITS PREPARATION |
2019 |
- Kim, Yunsam
- Kim, Myung Sic
- Shin, Dong Chul
- Hwang, Yongyoun
|
RU2796301C2 |
PHARMACEUTICAL COMBINATION FORMULATION CONTAINING AMLODIPINE, LOSARTAN AND ROSUVASTATIN |
2014 |
- Im Kho Taek
- Dzeong Mioung Ki
- Kim Jong Il
- Park Dzae Khiun
- Voo Dzong Soo
- Cho Khiuk Dzun
|
RU2660586C1 |
PHARMACEUTICAL COMPOSITION COMPRISING FIMASARTAN AND HYDROCHLOROTHIAZIDE |
2013 |
- Kim, Ju Won
- Kim, Je Hak
- Nam, Kyung Wan
- Kim, Sang Yeop
- Park, Seo Hun
|
RU2613900C2 |
PHARMACEUTICAL COMPLEX COMPOSITION CONTAINING AMLODIPINE, LOSARTAN AND ROSUVASTATIN |
2016 |
- Kim, Yong Il
- Im, Ho Taek
- Cho, Hyuk Jun
- Yoon, Youngsu
- Park, Jae Hyun
- Woo, Jong Soo
|
RU2724338C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC NEPHROPATHY |
2016 |
|
RU2702117C1 |
TABLET AND METHOD FOR PRODUCTION THEREOF |
2016 |
- Kim, Yun Sam
- Jeong, Sung Chan
- Myung, Jayhyuk
|
RU2697660C2 |
ORAL PHARMACEUTICAL COMPOSITION CONTAINING CARBAMATE COMPOUND, AND METHOD FOR ITS PREPARATION |
2020 |
- Lee, Ji Hye
- Choi, So Young
|
RU2829349C1 |
PHARMACEUTICAL COMPOSITION CONTAINING OLMESARTAN MEDOXOMIL AND ROSUVASTATIN OR ITS SALT |
2013 |
- Chang Hee-Chul
- Kang Bok-Ki
- Kim Jun-Ku
|
RU2616516C2 |
DOSAGE FORM WITH IMPROVED CHARACTERISTICS OF pH-DEPENDENT RELEASE OF PREPARATION CONTAINING ESOMEPRAZOLE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF |
2017 |
- Kwon, Taek Kwan
- Lee, Kwang Young
- Im, Ho Taek
- Kim, Yong Il
- Park, Jae Hyun
- Woo, Jong Soo
|
RU2716025C1 |